Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer... von Yardley, Denise A, Brufsky, Adam, Coleman, Robert E, Conte, Pierfranco F, Cortes, Javier, Glück, Stefan, Nabholtz, Jean-Mark A, O'Shaughnessy, Joyce, Beck, Robert M, Ko, Amy, Renschler, Markus F, Barton, Debora, Harbeck, Nadia

Volltext

Erratum to: 'Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative b... von Yardley, Denise A, Brufsky, Adam, Coleman, Robert E, Conte, Pierfranco F, Cortes, Javier, Glück, Stefan, Nabholtz, Jean-Mark A, O'Shaughnessy, Joyce, Beck, Robert M, Ko, Amy, Renschler, Markus F, Barton, Debora, Harbeck, Nadia

Volltext

Erratum to: Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative br... von Yardley, Denise A, Brufsky, Adam, Coleman, Robert E, Conte, Pierfranco F, Cortes, Javier, Glück, Stefan, Nabholtz, Jean-Mark A, O'Shaughnessy, Joyce, Beck, Robert M, Ko, Amy, Renschler, Markus F, Barton, Debora, Harbeck, Nadia

Volltext bestellen

Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer... von Yardley, Denise A, Brufsky, Adam, Coleman, Robert E, Conte, Pierfranco F, Cortes, Javier, Glueck, Stefan, Nabholtz, Jean-Mark A, O'Shaughnessy, Joyce, Beck, Robert M, Ko, Amy, Renschler, Markus F, Barton, Debora, Harbeck, Nadia

Volltext bestellen

Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations von Paik, Paul K, Felip, Enriqueta, Veillon, Remi, Sakai, Hiroshi, Cortot, Alexis B, Garassino, Marina C, Mazieres, Julien, Viteri, Santiago, Senellart, Helene, Van Meerbeeck, Jan, Raskin, Jo, Reinmuth, Niels, Conte, Pierfranco, Kowalski, Dariusz, Cho, Byoung Chul, Patel, Jyoti D, Horn, Leora, Griesinger, Frank, Han, Ji-Youn, Kim, Young-Chul, Chang, Gee-Chen, Tsai, Chen-Liang, Yang, James C.-H, Chen, Yuh-Min, Smit, Egbert F, van der Wekken, Anthonie J, Kato, Terufumi, Juraeva, Dilafruz, Stroh, Christopher, Bruns, Rolf, Straub, Josef, Johne, Andreas, Scheele, Jürgen, Heymach, John V, Le, Xiuning

Volltext

Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Can... von MARTY, Michel, COGNETTI, Francesco, KENNEDY, John, O'BYRNE, Kenneth, CONTE, Pier Franco, GREEN, Michael, WARD, Carol, MAYNE, Karen, EXTRA, Jean-Marc, MARANINCHI, Dominique, SNYDER, Ray, MAURIAC, Louis, TUBIANA-HULIN, Michèle, CHAN, Stephen, GRIMES, David, ANTON, Antonio, LLUCH, Ana

Volltext

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer von Hortobagyi, Gabriel N, Stemmer, Salomon M, Burris, Howard A, Yap, Yoon-Sim, Sonke, Gabe S, Paluch-Shimon, Shani, Campone, Mario, Blackwell, Kimberly L, André, Fabrice, Winer, Eric P, Janni, Wolfgang, Verma, Sunil, Conte, Pierfranco, Arteaga, Carlos L, Cameron, David A, Petrakova, Katarina, Hart, Lowell L, Villanueva, Cristian, Chan, Arlene, Jakobsen, Erik, Nusch, Arnd, Burdaeva, Olga, Grischke, Eva-Maria, Alba, Emilio, Wist, Erik, Marschner, Norbert, Favret, Anne M, Yardley, Denise, Bachelot, Thomas, Tseng, Ling-Ming, Blau, Sibel, Xuan, Fengjuan, Souami, Farida, Miller, Michelle, Germa, Caroline, Hirawat, Samit, O’Shaughnessy, Joyce

Volltext

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade von Prat, Aleix, Pascual, Tomás, De Angelis, Carmine, Gutierrez, Carolina, Llombart-Cussac, Antonio, Wang, Tao, Cortés, Javier, Rexer, Brent, Paré, Laia, Forero, Andres, Wolff, Antonio C, Morales, Serafín, Adamo, Barbara, Brasó-Maristany, Fara, Vidal, Maria, Veeraraghavan, Jamunarani, Krop, Ian, Galván, Patricia, Pavlick, Anne C, Bermejo, Begoña, Izquierdo, Miguel, Rodrik-Outmezguine, Vanessa, Reis-Filho, Jorge S, Hilsenbeck, Susan G, Oliveira, Mafalda, Dieci, Maria Vittoria, Griguolo, Gaia, Fasani, Roberta, Nuciforo, Paolo, Parker, Joel S, Conte, PierFranco, Schiff, Rachel, Guarneri, Valentina, Osborne, C Kent, Rimawi, Mothaffar F

Volltext

Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer von Villacampa, G., Tung, N.M., Pernas, S., Paré, L., Bueno-Muiño, C., Echavarría, I., López-Tarruella, S., Roche-Molina, M., del Monte-Millán, M., Marín-Aguilera, M., Brasó-Maristany, F., Waks, A.G., Pascual, T., Martínez-Sáez, O., Vivancos, A., Conte, P.F., Guarneri, V., Vittoria Dieci, M., Griguolo, G., Cortés, J., Llombart-Cussac, A., Muñoz, M., Vidal, M., Adamo, B., Wolff, A.C., DeMichele, A., Villagrasa, P., Parker, J.S., Perou, C.M., Fernandez-Martinez, A., Carey, L.A., Mittendorf, E.A., Martín, M., Prat, A., Tolaney, S.M.

Volltext

Phase III Trial of Observation Versus Six Courses of Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer in Complete Response After Six Courses of Paclitaxel/Platinum-Ba... von PECORELLI, Sergio, FAVALLI, Giuseppe, GADDUCCI, Angiolo, KATSAROS, Dionyssios, BENEDETTI PANICI, Pierluigi, CARPI, Amalia, SCAMBIA, Giovanni, BALLARDINI, Michela, NANNI, Oriana, CONTE, Pierfranco

Volltext

Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials von Dieci, M. V., Frassoldati, A., Generali, D., Bisagni, G., Piacentini, F., Cavanna, L., Cagossi, K., Puglisi, F., Michelotti, A., Berardi, R., Banna, G., Goubar, A., Ficarra, G., Griguolo, G., Conte, Pierfranco, Guarneri, V.

Volltext

Alpelisib (ALP) + fulvestrant (FUL) in patients (pts) with hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2−) advanced breast cancer (ABC):... von Juric, Dejan, Rugo, Hope S., Reising, Albert, Ma, Chong, Ciruelos, Eva M., Loibl, Sibylle, Singer, Christian F., Sohn, Joohyuk, Campone, Mario, Conte, Pierfranco, Iwata, Hiroji, Ghaznawi, Farhat, Miller, Michelle Kristine, Taran, Tetiana, Su, Fei, Andre, Fabrice

Volltext

Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis von Schettini, Francesco, Giuliano, Mario, Giudici, Fabiola, Conte, Benedetta, De Placido, Pietro, Venturini, Sergio, Rognoni, Carla, Di Leo, Angelo, Locci, Mariavittoria, Jerusalem, Guy, Del Mastro, Lucia, Puglisi, Fabio, Conte, PierFranco, De Laurentiis, Michelino, Pusztai, Lajos, Rimawi, Mothaffar F, Schiff, Rachel, Arpino, Grazia, De Placido, Sabino, Prat, Aleix, Generali, Daniele

Volltext

Abstract P4-10-04: Clinical outcomes of alpelisib in hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer by next-generation sequenci... von Juric, Dejan, Andre, Fabrice, Singer, Christian F., Sohn, Joohyuk, Campone, Mario, Loibl, Sibylle, Conte, Pierfranco, Iwata, Hiroji, Ciruelos, Eva, Mayer, Ingrid A., Reising, Albert, Ma, Chong, Miller, Michelle, Babbar, Naveen, Rugo, Hope S.

Volltext

A Catalyst for Change: The European Cancer Patient's Bill of Rights von Lawler, Mark, Le Chevalier, Thierry, Murphy, Martin J., Banks, Ian, Conte, Pierfranco, De Lorenzo, Francesco, Meunier, Françoise, Pinedo, H.M., Selby, Peter, Armand, Jean‐Pierre, Barbacid, Mariano, Barzach, Michèle, Bergh, Jonas, Bode, Gerlind, Cameron, David A., Braud, Filippo, Gramont, Aimery, Diehl, Volker, Diler, Sarper, Erdem, Sema, Fitzpatrick, John M., Geissler, Jan, Hollywood, Donal, Højgaard, Liselotte, Horgan, Denis, Jassem, Jacek, Johnson, Peter W., Kapitein, Peter, Kelly, Joan, Kloezen, Sandra, La Vecchia, Carlo, Löwenberg, Bob, Oliver, Kathy, Sullivan, Richard, Tabernero, Josep, Van de Velde, Cornelis J., Wilking, Nils, Wilson, Roger, Zielinski, Christoph, Hausen, Harald, Johnston, Patrick G.

Volltext

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fourth Symposium on Primary Systemic Therapy in the Managemen... von Berruti, Alfredo, Generali, Daniele, Kaufmann, Manfred, Puztai, Lajos, Curigliano, Giuseppe, Aglietta, Massimo, Gianni, Luca, Miller, William R., Untch, Michael, Sotiriou, Christos, Daidone, Mariagrazia, Conte, PierFranco, Kennedy, Derek, Damia, Giovanna, Petronini, Piergiorgio, Di Cosimo, Serena, Bruzzi, Paolo, Dowsett, Mitch, Desmedt, Christine, Mansel, Robert E., Olivetti, Lucio, Tondini, Carlo, Sapino, Anna, Fenaroli, Privato, Tortora, Gianpaolo, Thorne, Hather, Bertolini, Francesco, Ferrozzi, Francesco, Danova, Marco, Tagliabue, Elda, de Azambuja, Evandro, Makris, Andreas, Tampellini, Marco, Dontu, Gabriela, Van't Veer, Laura, Harris, Adrian L., Fox, Stephen B., Dogliotti, Luigi, Bottini, Alberto

Volltext

Abstract P5-02-32: Differential Gene Mutation Landscape in Patients With PIK3CA-altered and Non-altered Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-negative... von Juric, Dejan, Rugo, Hope, Reising, Albert, Ma, Chong, Ciruelos, Eva, Loibl, Sibylle, Singer, Christian F., Sohn, Joo Hyuk, Campone, Mario, Conte, PierFranco, Iwata, Hiroji, Ghaznawi, Farhat, Miller, Michelle, Taran, Tetiana, Su, Faye, Andre, Fabrice

Volltext

Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials von Dieci, M. V., Frassoldati, A., Generali, D., Bisagni, G., Piacentini, F., Cavanna, L., Cagossi, K., Puglisi, F., Michelotti, A., Berardi, R., Banna, G., Goubar, A., Ficarra, G., Griguolo, G., Conte, Pierfranco, Guarneri, V.

Volltext

The European Cancer Patient’s Bill of Rights, update and implementation 2016 von Lawler, Mark, Banks, Ian, Law, Kate, Albreht, Tit, Armand, Jean-Pierre, Barbacid, Mariano, Barzach, Michèle, Bergh, Jonas, Cameron, David, Conte, Pierfranco, de Braud, Filippo, de Gramont, Aimery, De Lorenzo, Francesco, Diehl, Volker, Diler, Sarper, Erdem, Sema, Geissler, Jan, Gore-Booth, Jola, Henning, Geoffrey, Højgaard, Liselotte, Horgan, Denis, Jassem, Jacek, Johnson, Peter, Kaasa, Stein, Kapitein, Peter, Karjalainen, Sakari, Kelly, Joan, Kienesberger, Anita, La Vecchia, Carlo, Lacombe, Denis, Lindahl, Tomas, Löwenberg, Bob, Luzzatto, Lucio, Malby, Rebecca, Mastris, Ken, Meunier, Françoise, Murphy, Martin, Naredi, Peter, Nurse, Paul, Oliver, Kathy, Pearce, Jonathan, Pelouchov, Jana, Piccart, Martine, Pinedo, Bob, Spurrier-Bernard, Gilly, Sullivan, Richard, Tabernero, Josep, Van de Velde, Cornelis, van Herk, Bert, Vedsted, Peter, Waldmann, Anita, Weller, David, Wilking, Nils, Wilson, Roger, Yared, Wendy, Zielinski, Christoph, zur Hausen, Harald, Le Chevalier, Thierry, Johnston, Patrick, Selby, Peter

Volltext

Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study von Curigliano, Giuseppe, Gómez Pardo, Patricia, Meric-Bernstam, F, Conte, Pierfranco, Lolkema, Martijn P, Beck, Joseph Thaddeus, Bardia, Aditya, Martínez-García, Maria, Pénault-Llorca, Frédérique, Dhuria, Shyeilla, Tang, Z, Solovieff, Nadia, Miller, Michelle, Di-Tomaso, Emmanuelle, Hurvitz, Sara A

Volltext